Outlook Therapeutics Inc (NASDAQ:OTLK) currently has a daily average trading volume of 554.29K but it saw 466419 shares traded in last market. With a market cap of 71.99M USD, the company’s current market price of $1.68 came falling about -0.59 while comparing to the previous closing price of $1.69. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.25 and as low as $0.87. In the recent trading on the day, stock has struck highest price mark of $1.65 while lowest mark touched by it was $1.73.
BTIG Research upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 27, 2024 while assigning a price target of $50. Chardan Capital Markets issued its recommendations for the stock as it upgraded the price target for the stock is $3.
Over the week, OTLK’s stock price is moving -6.15% down while it is -4.55% when we observe its performance for the past one month. Year-to-date it is -11.11% down and over the past year, the stock is showing a downside performance of -78.10%.
The company is expected to be releasing its next quarterly report on 2025-May-15, for which analysts forecasted an EPS of -0.43 while estimate for next year EPS is -1.94. In next quarter, company is expected to be making quarterly sales of $6.51M as analysts are expecting the sales for current fiscal year at $6.88M and seeing the company making $34.93M in sales next year. Moreover, analysts are in estimates of $1.66M for current-quarter revenue.
Currently, Outlook Therapeutics Inc’s total number of outstanding shares is 32.91M. Stock’s beta reads 0.31. Its return on asset (ROA) is 54.08% on average.
